(E)-Alprenoxime

Name	(E)-Alprenoxime
Synonyms	CDDD-1815 (E)-Alprenoxime 1-[2-(2-Propenyl)phenoxy]-3-isopropylaminoacetone (E)-oxime 2-Propanone, 1-[(1-methylethyl)amino]-3-[2-(2-propenyl)phenoxy]-, oxime, (E)- (9CI)
CAS	125720-84-5

Molecular Formula	C15H22N2O2
Molar Mass	262.34738
Density	1.02±0.1 g/cm3(Predicted)
Boling Point	398.7±37.0 °C(Predicted)
Solubility	DMSO
pKa	11.41±0.10(Predicted)
Storage Condition	-20℃
In vivo study	The purpose of the present study is to explore the pharmacological significance of Alprenoxime peripheral /βblocking activity in a non-rodent animal model. Interspecies scaling considerations predict that the doses selected in this study (1 and 5 mg/kg) are pharmacologically comparable or greater than doses used in rodent studies (2 and 6 mg/kg). More importantly, the prolonged ocular antihypertensive effects that are shown with 1% ophthalmic solutions indicate that the i.v. dose tested in the present study is likely to be more than two orders of magnitude greater than probable therapeutic doses.

Product Name: (E)-Alprenoxime Visit Supplier Webpage Request for quotation
CAS: 125720-84-5
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409

Wechat: 18301782025

Product Name: (E)-Alprenoxime Visit Supplier Webpage Request for quotation
CAS: 125720-84-5
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409

Wechat: 18301782025

View History

(E)-Alprenoxime

(E)-Alprenoxime Request for Quotation